N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-methylbenzenesulfonamide

ID: ALA562610

PubChem CID: 11452858

Max Phase: Preclinical

Molecular Formula: C19H19BrN2O2S

Molecular Weight: 419.34

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)NC2CCCc3c2[nH]c2ccc(Br)cc32)cc1

Standard InChI:  InChI=1S/C19H19BrN2O2S/c1-12-5-8-14(9-6-12)25(23,24)22-18-4-2-3-15-16-11-13(20)7-10-17(16)21-19(15)18/h5-11,18,21-22H,2-4H2,1H3

Standard InChI Key:  RQJJJEPZUUJDOD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   11.8769   -9.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1319   -9.8633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5799  -10.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0700   -8.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5179   -9.5202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7729  -10.3048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1054  -10.7897    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6929   -9.5202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4380  -10.3048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6310  -10.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0790   -9.8633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3339   -9.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1409   -8.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3761  -11.2610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4290   -8.4655    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    7.5691  -11.4325    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.7622  -11.6040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3976  -10.6255    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7406  -12.2395    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5072  -12.3887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7002  -12.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1482  -11.9471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4031  -11.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2101  -10.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3412  -12.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  3  6  2  0
 10 14  1  0
  6  7  1  0
  1 15  1  0
  7  9  1  0
 14 16  1  0
  8  5  1  0
 16 17  1  0
  8  9  2  0
 16 18  2  0
  1  2  2  0
 16 19  2  0
  5  4  2  0
 17 20  2  0
  4  1  1  0
 20 21  1  0
  5  6  1  0
 21 22  2  0
 22 23  1  0
  2  3  1  0
 23 24  2  0
 24 17  1  0
  8 13  1  0
 22 25  1  0
M  END

Associated Targets(Human)

HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human papillomavirus type 16 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 419.34Molecular Weight (Monoisotopic): 418.0351AlogP: 4.59#Rotatable Bonds: 3
Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.11CX Basic pKa: CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: -0.90

References

1. Gudmundsson KS, Boggs SD, Sebahar PR, Richardson LD, Spaltenstein A, Golden P, Sethna PB, Brown KW, Moniri K, Harvey R, Romines KR..  (2009)  Tetrahydrocarbazole amides with potent activity against human papillomaviruses.,  19  (15): [PMID:19556128] [10.1016/j.bmcl.2009.06.001]

Source